Carsten Schroeder appointed interim president of Novartis Diagnostics
October 31, 2011Sales and Marketing Novartis
Schroeder was previously vice president of Novartis Diagnostics for commercial operations in Europe, the Middle East and Africa. He will …
Novartis job cuts protest
October 31, 2011Manufacturing and Production, Sales and Marketing Novartis, job cuts, manufacturing and production
Protesters have been demonstrating outside the home of Novartis chairman Daniel Vasella and in the streets of Basel, Switzerland, in …
Core products boost Merck’s results
October 31, 2011Medical Communications, Sales and Marketing Gardasil, Merck, Victrelis
Sales of core products and favourable exchange rates have helped Merck grow its revenue in a tough environment. Worldwide sales …
Brilique gains NICE approval
October 31, 2011Sales and Marketing ACS, Brilique, NICE, Plavix, clopidogrel
AstraZeneca’s Brilique has been approved by NICE for use in combination with aspirin as an option to treat patients with …
Boehringer agrees Pradaxa kidney function warning
October 30, 2011Sales and Marketing AF, EMA, Pradaxa, renal function
Boehringer Ingelheim is to alert doctors in Europe of the need to check patients’ kidney function before prescribing anticoagulant Pradaxa. …
Dr Reddy’s says two plants clear FDA inspections
October 28, 2011Manufacturing and Production Dr Reddy's, FDA 483s, India, generics
Two manufacturing facilities operated by Indian drugmaker Dr Reddy’s Laboratories successfully passed inspections by the FDA, although a plant in …
Emerging markets help Bayer through tough quarter
October 28, 2011Sales and Marketing Bayer, Xarelto, emerging markets
Bayer has posted modest results for the third quarter, with growth in emerging markets compensating for austerity measures in Europe …
PM Society appoints new general manager
October 28, 2011Medical Communications pm society
The Pharmaceutical Marketing Society has appointed Anneliese Cameron as its new general manager. Anneliese will be joining the Society on …
Publicis merges digital agencies into larger group
October 28, 2011Medical Communications Digitas Health, Razorfish, digital, publicis
Digital agencies Digitas Health and Razorfish Health are to be merged into the larger Publicis Healthcare Communications Group (PHCG).PHCG is …
AstraZeneca weathers patent expiry storm
October 27, 2011Sales and Marketing AstraZeneca, AstraZenecca, q3 2011
AstraZeneca saw its revenue decline in the third quarter due to an onslaught of patent expiries, but still saw its …
Lessons from the world of iPad detailing
October 27, 2011Medical Communications
This is an article for those who have chosen the iPad as an e-detailing tool. It’s not an argument on …
Alex Butler leaves Janssen to set up Social Moon pharma network
October 27, 2011Medical Communications Alex Bytler, Jansse, Janssen, comms
Social media guru Alex Butler has left Janssen to establish Social Moon, a digital-only marketing and comms agency for the …
Lansley talks tough on failing hospitals
October 27, 2011Medical Communications Andrew Lansley, NHS reforms
The health secretary Andrew Lansley says he will intervene to remove management boards of hospitals which can’t clear debts or …
Biogen’s MS drug hits phase III targets
October 27, 2011Sales and Marketing BG-12, Biogen, MS
Biogen’s potential blockbuster MS drug BG-12 has met its primary endpoint in a late-stage trial. BG-12 (dimethyl fumarate) tablets …
GSK sees strong Q3 after battling headwinds
October 27, 2011Business Services, Sales and Marketing GSK, GSK. Q3, Q3
GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
Mepact wins NICE backing
October 26, 2011Research and Development, Sales and Marketing Mepact, NICE
NICE has recommended Takeda’s bone cancer drug Mepact after the firm offered a discount for the treatment. The watchdog’s final …
Reforms raise conflicts of interest, say GPs
October 25, 2011Sales and Marketing BMA, NHS, NHS reforms
Two-thirds of doctors believe that the government’s health reforms will create conflicts of interests in their jobs and undermine their …
Novartis to cut 2,000 jobs
October 25, 2011Manufacturing and Production, Research and Development
Novartis will cut around 2,000 jobs is the US and Switzerland as part of additional cost saving measures. The positions …
David Meeker appointed as chief executive of Genzyme
October 25, 2011Research and Development, Sales and Marketing Genzyme, Sanofi
Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …
Pharma manufacturing news in brief
October 25, 2011Manufacturing and Production pharma manufacturing news
Patheon wins a new contract from Boehringer Ingelheim, Ferring buys a UK plant, plus updates from InvaGen, CrossJect and contract …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
